Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

NCMN 109A - Pedia Lecture > Dermatologic Problems in the Newborn > Flashcards

Dermatologic Problems in the Newborn Flashcards

1
Q

Benign; self-limiting eruption; usually appears within the first 2 days of life

A

Erythema Toxicum Neonatorum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Erythema Toxicum Neonatorum is also known as

A

fleabite dermatitis or newborn rash

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

is Erythema Toxicum Neonatorum benign or malignant?

A

benign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Erythema Toxicum Neonatorum usually appears within the

A

first 2 days of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Description of Erythema Toxicum Neonatorum

A

1-3 mm lesion; firm, pale yellow or white papules or pustules on an erythematous base

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Fill in the blanks:
Erythema Toxicum Neonatorum commonly disappears in ________________ and reappears ___________________

A

one location; elsewhere hours later

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Erythema Toxicum Neonatorum appears on the?

A

face, proximal extremities, trunk, and buttocks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

does Erythema Toxicum Neonatorum have systemic manifestations?

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Erythema Toxicum Neonatorum rash lasts?

A

5-7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

cause of Erythema Toxicum Neonatorum

A

Cause is unknown also numerous eosinophils and absence of neutrophils is noted on smear of pustule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Nursing Care Management for Erythema Toxicum Neonatorum

A
  • No treatment necessary
  • Reassure parents that it is benign and transient in nature
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Candidiasis is also known as

A

Moniliasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Candidiasis is caused by

A

candida albicans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Acquisition of Candidiasis

A
  1. Can be acquired from a maternal vaginal infection during delivery
  2. By person-to-pers on transmission
  3. From contaminated hands, bottles, nipples or other articles
  4. Usually benign and is often confined to oral and diaper regions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Characterized by white adherent patches on the tongue, palate and inner aspects of the cheeks

A

ORAL CANDIDIASIS (THRUSH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Happens when oral flora are altered as a result of antibiotic therapy or poor hand washing by the caregiver

A

ORAL CANDIDIASIS (THRUSH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Description of Oral Candidiasis (Thrush)

A

white adherent patches on the tongue, palate and inner aspects of the cheeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

cause of Oral Candidiasis (Thrush)

A

Happens when oral flora are altered as a result of antibiotic therapy or poor hand washing by the caregiver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Infant may refuse to suck because of pain in the mouth

A

Oral Candidiasis (Thrush)

19
Q

Oral Candidiasis (Thrush)

Self-limiting; spontaneous resolution within ________________

20
Q

Oral Candidiasis (Thrush)

By this time (2 months), lesions may spread to the _________________________________________________

A

larynx, trachea, bronchi, and lungs and along the GI tract

21
Q

Oral Candidiasis (Thrush)

Disease is treated with _____________________________________________________________________________________________

A

good hygiene, application of fungicide, and correction of underlying disturbance

22
Q

General Nursing Care Management for Oral Candidiasis (Thrush)

A

Directed toward preventing spread of infection and correct application of the prescribed topical medication

23
Q

Nursing Care Management for Oral Candidiasis (Thrush)
Diaper Area

A

Keep diaper area clean and apply medication to affected areas as prescribed

24
Q

Nursing Care Management for Oral Candidiasis (Thrush)

Meds

  • ________________ is administered after feedings
  • Medication is distributed over the_______________________________ and _____ with an applicator or syringe
  • The remainder of the dose is deposited in the ___________ to be swallowed by the infant to treat any gastrointestinal lesions
A

Oral Nystatin; surface of the oral mucosa; tongue; mouth

25
Q

Nursing Care Management for Oral Candidiasis (Thrush)

GOOD HYGIENE CARE

  • RINSE INFANT’S MOUTH WITH _____________ AFTER EACH FEEDING BEFORE APPLYING MEDICATION
  • BOIL REUSABLE NIPPLES AND BOTTLES FOR AT LEAST _______________________ AFTER THOROUGH WASHING
  • PACIFIERS SHOULD BE BOILED FOR _____________________________________
  • _____________ OF BREAST-FEEDING MOTHERS SHOULD BE TREATED TO PREVENT REINFECTION
A

PLAIN WATER ; 20 MINUTES; AT LEAST 20 MINUTES ONCE DAILY; NIPPLES

26
Q

ONE OF THE MOST SERIOUS VIRAL INFECTIONS MORTALITY RATE 60% (DISSEMINATED DISEASE)

27
Q

Types of Herpes

A
  1. SKIN, EYE & MOUTH;
  2. LOCALIZED CNS DISEASE;
  3. DISSEMINATED INFECTION (MULTIPLE SITES)
28
Q

______________ OF HSV TRANSMISSION OCCURS DURING DELIVERY

29
Q

86%-90% OF HSV TRANSMISSION OCCURS DURING ________________

30
Q

Description of Herpes

A

RASH APPEARS AS VESICLES OR PUSTULES ON AN ERYTHEMATOUS BASE

31
Q

COMMONLY THE PRIMARY SIRE OF INFECTION OF HERPES

A

FETAL SCALP MONITORING SITE

32
Q

HERPES MAY ALSO MANIFEST OPTHALMOLOGIC CLINICAL FINDINGS SUCH AS?

A

CHORIORETINITIS, MICROPTHALMIA

33
Q

IN HERPES, CNS INVOLVEMENT COULD OCCUR SUCH AS

A

MICROCEPHALY ENCEPHALOMALACIA

34
Q

AN INFECTIOUS SUPERFICIAL SKIN CONDITION

A

BULLOUS IMPETIGO

35
Q

CAUSATIVE AGENT OF BULLOUS IMPETIGO

A

Staphylococcus aureus

36
Q

DESCRIPTION OF BULLOUS IMPETIGO

A

ERUPTED BULLOUS VESICULAR LESIONS ON INTACT SKIN

37
Q

USUAL DISTRIBUTION OF BULLOUS IMPETIGO INCLUDES

A

BUTTOCKS, PERINEUM, TRUNK, FACE & EXTREMITIES

38
Q

SIZE OF BULLOUS IMPETIGO

A

VARY IN SIZE FROM A FEW MILLIMETERS TO SEVERAL CENTIMETERS

39
Q

IN BULLOUS IMPETIGO, RUPTURED BULLAE LEAVES A

A

SUPERFICIAL RED, MOIST, DENUDED AREA WITH LITTLE CRUSTING

40
Q

IN BULLOUS IMPETIGO, RECOVERY IS

A

RAPID AND UNEVENTFUL

41
Q

TREATMENT OF BULLOUS IMPETIGO

A
  • ORAL ANTIBIOTICS
  • TOPICAL APPLICATION OF MUPIROCIN
42
Q

NURSING CARE MANAGEMENT OF BULLOUS IMPETIGO

A
  • ISOLATION UNTIL THERAPY IS INSTITUTED
  • HAND WASHING AND STANDARD PRECAUTION
  • ELBOW RESTRAINTS OR APPLYING MITTENS TO PREVENT SCRATCHING THE LESIONS
  • IF RESTRAINTS ARE USED, INFANT IS ALLOWED FREEDOM OF MOVEMENT AT SUPERVISED TIMES
  • ESSENTIAL COMPONENTS OF CARE INCLUDE ROCKING, CUDDLING AND HOLDING DURING FEEDING
43
Q

Discoloration of the skin

A

BIRTHMARKS

44
Q

NURSING CARE MANAGEMENT OF BIRTHMARKS

A
  • EXPLAIN TO THE FAMILY THE TYPE OF LESION, SIGNIFICANCE AND POSSIBLE TREATMENT
  • IF LASER THERAPY IS PERFORMED, LESION WILL HAVE A PURPLISH BLACK APPEARANCE FOR 7-10 DAYS THEN
    LIGHTENS THEREAFTER
  • CAUTION PARENTS TO AVOID ANY TRAUMA TO THE LESION OR PICKING AT THE SCAB
  • TRIM FINGERNAILS OF INFANT AS AN ADDED PRECAUTION
  • WASH AREA GENTLY WITH WATER AND DRY IT
  • APPLY TOPICAL ANTIBIOTIC OINTMENT AS PRESCRIBED; AVOID SALICYLATES
  • KEEP INFANT AWAY FROM THE SUN FOR SEVERAL WEEKS AND PROTECT WITH SUNCREEN (SPF 15)
  • WATCH OUT FOR SIGNS OF COMPLICATION OF THERAPY SUCH AS INFECTION, KELOID OR PYOGENIC GRANULOMA FORMATION, LOCALIZED DERMATITIS, HYPER- OR HYPOPIGMENTATION

NCMN 109A - Pedia Lecture (8 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions